April 25, 2018 2:41 PM ET

Pharmaceuticals

Company Overview of ErgoNex Pharma GmbH

Company Overview

ErgoNex Pharma GmbH, a clinical development company, identifies and develops well-tolerated and effective products for novel and typically underserved indications. It engages in the clinical development and commercialization of Terguride for the treatment of distinct orphan diseases. The company was founded in 2004 and is based in Appenzell, Switzerland.

Rütistrasse 20

Appenzell,  9050

Switzerland

Founded in 2004

Phone:

41 71 788 40 65

Fax:

41 71 788 40 69

Key Executives for ErgoNex Pharma GmbH

Chief Executive Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Acino International AG Europe
Activen SA Europe
AL-S Pharma AG Europe
Albea Pharmaceuticals AG Europe
Alpen Pharma AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ErgoNex Pharma GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.